R
RedDress
Advanced biologic wound care solutions revolutionizing chronic wound treatment with natural healing processes
About RedDress
RedDress Medical is a healthcare company focused on revolutionizing the treatment of chronic wounds through advanced biologic wound care solutions. Founded in 2009 by Dr. Igal Kushnir MD and Alon Kushnir, the company aims to develop more effective, natural, and economically viable treatments for chronic wounds. RedDress Medical's flagship product, ActiGraft, leverages proprietary, patented technology to recreate the body's natural wound healing processes, offering a cost-effective solution for managing difficult wounds. The company serves a diverse range of clients, including hospitals, clinics, and healthcare providers, primarily in the chronic wound care market. RedDress Medical operates on a B2B (business-to-business) model, generating revenue through the sale of its innovative wound care products to medical institutions. The company's mission is to improve the health and lives of patients worldwide by providing advanced, cost-effective chronic wound treatments that benefit both patients and medical professionals.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Ponte Vedra Beach, United States
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 62.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | May 2023 | $26M | $104M | HCS Capital Partners · Athos therapeutics · Ragnar | ↗ |
| ANGELEquity / VC | Sep 2010 | $0 | — | Boston Harbor Angels | — |
Growth signals
Latest recorded traffic for RedDress is 3.8K monthly website visits, up 46.2% over the last three months. RedDress's team declined 3.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Boston Harbor Angels
Series B and later3 investors entered at this stage
HCS Capital Partners
Athos therapeutics
Ragnar
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about RedDress on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RedDress’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.